Apoptosis control and proliferation marker in human normal and neoplastic adrenocortical tissues

British Journal of Cancer

Volumn 86, Issue 10, 2002, Pages 1561-1565

  Bernini, G P ^a   Moretti, A ^a   Viacava, P ^a   Bonadio, A G ^a   Iacconi, P ^a   Miccoli, P ^a   Salvetti, A ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Adrenal cortex; Adrenocortical tumours; Bcl 2; Ki 67; P53

Indexed keywords

KI 67 ANTIGEN; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PROTEIN P53;

ADRENAL CORTEX CELL; ADRENAL CORTEX TUMOR; ADULT; AGED; APOPTOSIS; ARTICLE; CANCER GROWTH; CELL DEATH; CELL PROLIFERATION; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; ADENOMA; ADRENAL CORTEX; ADRENAL CORTEX NEOPLASMS; ADULT; AGED; ALDOSTERONE; ANTIGENS, NUCLEAR; APOPTOSIS; CELL DIVISION; FEMALE; HUMANS; KI-67 ANTIGEN; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0037141348     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600287     Document Type: Article

References (31)

1. Coexpression of p53 and tissue transglutaminase genes in human normal and pathologic adrenal tissues
2. The p53 network
3. Molecular analysis of CDKN1C and TP53 in sporadic adrenal tumors
4. DNA sequence analysis of exons 2 through 11 and immunohistochemical staining are required to detect ali known p53 alterations in human malignancies
5. Genetic basis for p53 overexpression in human breast cancer
6. Bcl-2 expression in normal adrenal glands and in adrenal neoplasms
7. Tumour angiogenesis and prognosis
8. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67
9. Immunohistochemical assessment of proliferative activity in adrenocortical neoplasms
10. Immunohistochemical markers of cellular proliferation: Achievements, problems and prospects
11. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death
12. Bcl-2 functions in ah antioxidant pathway of apoptosis
13. P53 mutations in human cancers
14. DNA topoisomerase 11β and Ki-67 in human adrenocortical neoplasms: A possible marker of differentiation between adenomas and carcinomas
15. Tumors of the adrenal gland and extra-adrenal paraganglia in
16. Bcl-2 in normal breast and carcinoma, association with estrogen receptor-positive, epidermal growth factor receptor-negative tumours and in situ cancer
17. Mutations of the p53 gene in human functional adrenal neoplasms
18. Cancer of the adrenal cortex: The natural history, prognosis and treatment in a study of fifty-five cases
19. Bcl-2, p53 and MIB-1 expression in normal and neoplastic parathyroid tissues
20. Expression of cell cycle inhibitor p27 and Ki-67 in human adrenocortical neoplasm
21. P53 mutations in sporadic adrenocortical tumors
22. Bcl-2 protein expression in carcinomas originating from the follicular epithelium of the thyroid gland
23. P53 mutations in human adrenocortical neoplasms: Immunohistochemical and molecular studies
24. P53 mutations in adrenal tumors: Caucasian patients do not show the exon 4 'Hot Spot' found in Taiwan
25. Cell proliferation and apoptosis in normal and pathologic human adrenal
26. Bcl-2 expression in the spectrum of preinvasive breast lesions
27. Discerning malignancy in human adrenocortical neoplasms: Utility of DNA flow cytometry and immunohistochemistry
28. The role of prognostic markers (MIB-1, RB, and bcl-2) in the diagnosis of parathyroid tumors
29. Biological and clinical importance of the p53 tumor suppressor gene
30. Different proliferative patterns characterize different preinvasive breast lesions
31. Adrenal cortical carcinoma